Delafloxacin

(Baxdela®)

Baxdela®

Drug updated on 11/13/2023

Dosage FormTablet (oral: 450 mg); Injection (Intravenous: 300 mg)
Drug ClassFluoroquinolone antibacterials
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • For the treatment of adults with acute bacterial skin and skin structure infections (ABSSSI) caused by designated susceptible bacteria.
  • For the treatment of adults with community-acquired bacterial pneumonia (CABP) caused by designated susceptible bacteria.